Related Links
Nucleoside Reverse Transcriptase Inhibitors (NRTI's)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI's)
Protease Inhibitors (PI)
Fusion Inhibitors (FI's)
Updated:
As this is the NEW website for the AIDS Committee of Windsor, AIDS Support Chatham-Kent, and the Drouillard Road Clinic, everything is new and in the process of being updated. If by chance there is anything wrong with the information, feel free to contact us.

Treatment Information
Fusion Inhibitors (FI's)
Drugs known as entry inhibitors and fusion inhibitors are being developed to prevent HIV from getting into cells. Entry inhibitors are designed to block the receptors HIV uses to attach itself to cells. Fusion inhibitors prevent the virus from fusing with the cell.
Side Effects
The most common side effects of fusion inhibitors include injection site redness, swelling, soreness and in some cases patients experience headache, dizziness and in extreme cases a few have reported rash, fever, and vomiting.
Fusion Inhibitors have not been approved in Canada to date, however, it is expected that T-20, the first of this class, will be approved for use in Canada by Autumn 2003.
